Ho Chi Sing - Dec 30, 2024 Form SCHEDULE 13D/A Schedule Report for CASI Pharmaceuticals, Inc. (CASI)

Filing Manager
Ho Chi Sing
Reporting Manager
Quan Zhou
Security
CASI Pharmaceuticals, Inc. Ordinary Shares, $0.0001 par value
Symbol
CASI
Shares outstanding
15.5M shares
Disclosed Ownership
993K shares
Ownership
6.4%
Form type
SCHEDULE 13D/A
Date filed
2/3/2025, 08:17 PM
Date of event
Dec 30, 2024
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
IDG-Accel China Growth Fund III L.P. 5.9% 916K 855K 60.6K /s/ Chi Sing Ho on behalf of IDG-Accel China Growth Fund GP III Associates Ltd., ultimate General Partner of IDG-Accel China Growth Fund III L.P. Chi Sing Ho / Authorized Signatory 0001508829
IDG-Accel China III Investors L.P. 5.9% 916K 60.6K 855K /s/ Chi Sing Ho on behalf of IDG-Accel China Growth Fund GP III Associates Ltd., General Partner of IDG-Accel China III Investors L.P. Chi Sing Ho / Authorized Signatory 0001550193
IDG-Accel China Growth Fund III Associates L.P. 5.9% 916K 855K 60.6K /s/ Chi Sing Ho on behalf of IDG-Accel China Growth Fund GP III Associates Ltd., General Partner of IDG-Accel China Growth Fund III Associates L.P. Chi Sing Ho / Authorized Signatory 0001550192
IDG-Accel China Growth Fund GP III Associates Ltd. 5.9% 916K 916K 0 /s/ Chi Sing Ho Chi Sing Ho / Authorized Signatory 0001564281
Ho Chi Sing 5.9% 916K 0 916K /s/ Ho Chi Sing Ho Chi Sing 0001545806
Quan Zhou 6.4% 993K 76.8K 916K /s/ Quan Zhou Quan Zhou 0001491503